Cargando…
Individual recombinant repeats of MUC16 display variable binding to CA125 antibodies
BACKGROUND: Despite its importance in the clinical management of ovarian cancer, the CA125 biomarker—located on the mucin protein MUC16—is still not completely understood. Questions remain about MUC16’s function and structure, specifically the identity and location of the CA125 epitopes. OBJECTIVE:...
Autores principales: | Wang, Chien-Wei, Hanson, Eliza K., Minkoff, Lisa, Whelan, Rebecca J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934600/ https://www.ncbi.nlm.nih.gov/pubmed/36798296 http://dx.doi.org/10.1101/2023.02.08.527749 |
Ejemplares similares
-
CA125/MUC16 Is Dispensable for Mouse Development and Reproduction
por: Cheon, Dong-Joo, et al.
Publicado: (2009) -
MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress
por: Felder, Mildred, et al.
Publicado: (2014) -
Polymorphisms of MUC16 (CA125) and MUC1 (CA15.3) in Relation to Ovarian Cancer Risk and Survival
por: Williams, Kristina A., et al.
Publicado: (2014) -
Mesothelin Binding to CA125/MUC16 Promotes Pancreatic Cancer Cell Motility and Invasion via MMP-7 Activation
por: Chen, Shih-Hsun, et al.
Publicado: (2013) -
Conflicting Views on the Molecular Structure of the Cancer Antigen CA125/MUC16
por: Bouanene, Houda, et al.
Publicado: (2010)